Urocortin is a 40-amino acid peptide belonging to the corticotropin-releasing factor (CRF) family. In human reproductive tissues, urocortin expression has been previously demonstrated in the ovary, in the placenta and fetal membranes and in pregnant uterine tissues, while no data are available on the expression of the peptide in the nonpregnant uterus. In this study, urocortin expression was evaluated by both immunohistochemistry and reverse transcription-polymerase chain reaction, in human uterine tissues and cells at different phases of the menstrual cycle. Urocortin was immunolocalized in endometrial epithelial and stromal cells, as well as in the myometrium, and in vascular smooth muscle cells. No differences between proliferative and secretory phase were observed. These results were confirmed by reverse transcription-polymerase chain reaction analysis of isolated endometrial epithelial and stromal cells, and myometrial specimens. These findings open new questions on the roles played by urocortin in the human uterus.
You are looking at 1 - 2 of 2 items for
- Author: P Florio x
- Refine by Access: All content x
P Florio, F Arcuri, P Ciarmela, Y Runci, R Romagnoli, M Cintorino, AM Di Blasio, and F Petraglia
F Petraglia, A M Di Blasio, P Florio, R Gallo, A R Genazzani, T K Woodruff, and W Vale
The aim of the present study was to evaluate whether spontaneous labor at term and pathological preterm labor are associated with changes in the expression of activin A and activin receptor mRNAs in fetal membranes. In addition, amniotic fluid activin A concentration in women delivering at term or undergoing preterm labor was also measured.
The expression of activin βA subunit and activin receptor type II and type IIB mRNAs was assessed by reverse transcriptase-PCR on specimens of amnion and chorion collected from patients delivering at term or undergoing preterm labor. Control specimens were collected from women delivered by elective cesarean section who had not experienced labor.
A specific two-site ELISA was used to measure activin A concentrations in the amniotic fluid. A cross-sectional study of amniotic fluid retrieved by amniocentesis from 109 pregnant women was carried out. Patients were classified into the following groups: (1) healthy controls at term but not in labor (n=25); (2) healthy controls at term in spontaneous labor (n=40); (3) healthy controls between 23 and 36 weeks of gestation (n=12); (4) patients in preterm labor responding to tocolytic treatment (n=19); (5) patients in preterm labor with subsequent delivery (n=13).
Activin βA subunit and activin receptor type IIB mRNA levels in both the chorion and amnion in women delivering at term or after preterm labor were significantly higher than in women delivering without undergoing labor (P<0·01). Expression of activin receptor type II mRNA in membranes did not differ among the three groups of women. Amniotic fluid activin A concentration in patients in labor was significantly higher than in those at term but not in labor (P<0·01). Patients in preterm labor had significantly higher amniotic fluid activin A concentrations than women at the same stage of gestation (P<0·01). The highest values were found in women undergoing preterm labor and subsequent delivery.
In conclusion, spontaneous labor and preterm labor are characterized by increased synthesis and release of activin A from amniotic and chorionic cells and by an augmented expression of activin type IIB receptor.
Journal of Endocrinology (1997) 154, 95–101